Skip to main content
Veterinary Medicines

Arocenia, 10mg/ml, Solution for injection

Authorised
  • Maropitant

Product identification

Medicine name:
Arocenia, 10mg/ml, Solution for injection
Arocenia, 10 mg/mL, otopina za injekciju, za pse i mačke
Active substance:
  • Maropitant
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Maropitant
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA04AD90
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:
  • Glass Vial 1 x 20.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
  • Tad Pharma GmbH
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/23-01/643
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0179/001
Concerned member states:
  • Belgium
  • Croatia
  • Estonia
  • Germany
  • Hungary
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 2/01/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."